Insider Selling: Neogen Corp. (NEOG) CFO Sells 3,000 Shares of Stock

Neogen Corp. (NASDAQ:NEOG) CFO Steven J. Quinlan sold 3,000 shares of Neogen Corp. stock in a transaction on Monday, November 14th. The stock was sold at an average price of $61.28, for a total transaction of $183,840.00. Following the sale, the chief financial officer now directly owns 13,103 shares in the company, valued at approximately $802,951.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Neogen Corp. (NASDAQ:NEOG) opened at 61.42 on Wednesday. The stock’s 50 day moving average price is $54.49 and its 200 day moving average price is $54.46. Neogen Corp. has a 12-month low of $43.79 and a 12-month high of $62.55. The stock has a market cap of $2.32 billion, a price-to-earnings ratio of 62.67 and a beta of 1.50.

Neogen Corp. (NASDAQ:NEOG) last released its quarterly earnings data on Tuesday, September 27th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.26. The firm earned $83.65 million during the quarter. Neogen Corp. had a return on equity of 9.36% and a net margin of 11.25%. The company’s revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.25 EPS. Analysts forecast that Neogen Corp. will post $1.12 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Neogen Corp. (NASDAQ:NEOG)

NEOG has been the topic of several recent research reports. Craig Hallum cut shares of Neogen Corp. from a “buy” rating to a “hold” rating in a research note on Monday, August 29th. Zacks Investment Research cut shares of Neogen Corp. from a “hold” rating to a “sell” rating in a research note on Saturday, July 23rd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $58.25.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its position in Neogen Corp. by 126.9% in the first quarter. BlackRock Inc. now owns 2,512 shares of the company’s stock valued at $126,000 after buying an additional 1,405 shares during the last quarter. State Street Corp boosted its position in Neogen Corp. by 3.2% in the first quarter. State Street Corp now owns 759,676 shares of the company’s stock valued at $38,252,000 after buying an additional 23,679 shares during the last quarter. Geode Capital Management LLC boosted its position in Neogen Corp. by 5.6% in the first quarter. Geode Capital Management LLC now owns 257,398 shares of the company’s stock valued at $12,959,000 after buying an additional 13,715 shares during the last quarter. Kennedy Capital Management Inc. boosted its position in Neogen Corp. by 2.6% in the first quarter. Kennedy Capital Management Inc. now owns 31,621 shares of the company’s stock valued at $1,592,000 after buying an additional 790 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its position in Neogen Corp. by 107.1% in the second quarter. BNP Paribas Arbitrage SA now owns 11,714 shares of the company’s stock valued at $659,000 after buying an additional 6,058 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Neogen Corp.

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

5 Day Chart for NASDAQ:NEOG

Receive News & Ratings for Neogen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corp. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2016 Mideast Time.